ClearStain™
Direct virtual H&E from unstained slides for molecular testing
Software · HybridCompany source
Company profile
About Pictor Labs
Pictor Labs is a virtual staining technology company that replaces traditional chemical staining with AI-powered digital staining for pathology and laboratory diagnostics. The company's platform generates diagnostic-quality virtual stains including H&E, IHC, and special stains in minutes rather than hours or days, while preserving tissue samples for downstream analysis. Pictor Labs offers three core products: ClearStain™ for direct virtual H&E generation from unstained slides for molecular testing workflows, DeepStain™ for virtual histological staining from label-free tissue using autofluorescence imaging, and ReStain for virtual re-staining of existing H&E images. The technology is trained on expertly curated, co-registered image pairs and provides consistent, high-quality visualization across multiple laboratory sites. The platform integrates into existing workflows with flexible deployment options including cloud and on-premise environments, and is compatible with leading scanner platforms. Pictor Labs serves biopharma companies, contract research organizations (CROs), academic medical centers, and veterinary pathology labs. The company's technology addresses critical workflow challenges including tissue preservation, turnaround time reduction, staining consistency across sites, and maximizing analytical insight from limited biopsy material. Currently offered for research use only (RUO), the virtual staining outputs are reviewed by qualified pathologists and designed to support visualization and workflow flexibility rather than replace medical expertise.
Company description Pictor Labs official website
Primary marketPathology & Laboratory Diagnostics
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Pictor Labs?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cancer research
- Classic Hodgkin lymphoma
- Lung carcinomas
- Lymphomas
- Tumor microenvironment analysis
Who it serves
- Academic medical centers
- Biopharma companies
- Contract Research Organizations (CROs)
- Research institutions
- Veterinary pathology labs
Deployment & integration
Hybrid deployment with recorded integration context.
Recorded integration context: Leading scanner platforms, Leica Biosystems.
Geographic context
MarketsGlobal deployment mentioned · Multi-site studies
Company sourceOfficial website
Company milestones
Platform expansion
Presented research at SITC 2024, AACR 2024, and USCAP 2024. Deployed with leading biopharma companies, CROs, and academic medical centers for real-world workflow integration.
Partnerships
Recorded partners
- Johns Hopkins
- Leica Biosystems
- UCLA
- University of Maryland
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
DeepStain™
Virtual histological staining from label-free tissue autofluorescence
Software · HybridCompany source
ReStain
Virtual re-staining from existing H&E tissue images
Software · HybridCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Febrile transfusion-associated circulatory overload in adult oncology patients.Vox sanguinis · Jun 1, 2026
Applications and challenges of utilizing digital pathology and AI-enabled workflows in clinical trials.Journal of pathology informatics · Jan 1, 2026
Deep learning accelerates whole slide imaging for next-generation digital pathology applications.Light, science & applications · Oct 14, 2022
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Speed
Minutes to results versus hours or days for chemical processing
Tissue preservation
Full-spectrum testing from one slide reduces QNS (quantity not sufficient) results
Workflow acceleration
Reduces turnaround time across multi-site studies
Tissue utilization
Multiple stain views from a single scanned slide
Leica Biosystems and University of Maryland
Multi-modal spatial analysis of classic Hodgkin lymphoma microenvironment utilizing virtual H&E for regulatory T-cell subtyping
Demonstrated virtual H&E enables regulatory T-cell subtyping and tumor microenvironment analysis in cancer research at SITC 2024
University of Maryland, Johns Hopkins, UCLA
Assessment of AI computational H&E staining versus chemical H&E staining for primary diagnosis in lymphomas
Presented comparative study at USCAP 2024 demonstrating diagnostic equivalence
Biopharma Company
Maximizing tissue value across drug development programs by generating multiple stains from single slides while maintaining consistent stain appearance
Preserved tissue for downstream molecular and spatial assays, reduced need for additional sectioning, supported consistent visual staining standard across studies and sites
Global CRO (Contract Research Organization)
Reducing turnaround time across multi-site clinical trials by eliminating chemical processing delays and slide shipping dependencies
Accelerated access to stain outputs across sites, reduced workflow bottlenecks and shipping dependencies, enabled on-demand reanalysis
Veterinary Pathology Laboratory
Expanding analytical insight from limited biopsy material while preserving tissue for future molecular testing
Enabled broader pathological evaluation from single scanned slide, supported more consistent stain appearance across global laboratory networks
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Pictor Labs
Recent articles published on Pictor Labs's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Pathology & Laboratory Diagnostics
Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.